What is the initial dose of norepinephrine (vasopressor) for treating hypotension?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 27, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Initial Norepinephrine Dosing for Hypotension

Start norepinephrine at 0.02 mcg/kg/min (approximately 8-12 mcg/min for a 70 kg adult) via continuous IV infusion, targeting a mean arterial pressure (MAP) of 65 mmHg. 1

Critical Pre-Administration Requirements

Before starting norepinephrine, administer at least 30 mL/kg crystalloid bolus (approximately 2 liters for a 70 kg adult) unless the patient has profound, life-threatening hypotension. 1, 2

  • Use balanced crystalloids (lactated Ringer's or Plasma-Lyte) preferentially over normal saline for fluid resuscitation 3
  • In cases of severe hypotension (systolic BP <70 mmHg) or diastolic BP ≤40 mmHg, start norepinephrine immediately while fluid resuscitation continues rather than waiting for complete volume repletion 2, 4
  • Early norepinephrine administration (within 93 minutes of presentation) significantly increases shock control rates compared to delayed administration and reduces fluid overload complications 5

Preparation and Concentration

Standard dilution: Add 4 mg norepinephrine to 250 mL of D5W to yield 16 mcg/mL concentration. 6

  • Alternative concentration: Add 4 mg to 1000 mL D5W for 4 mcg/mL if larger fluid volumes are needed 6
  • Do not dilute in saline alone—dextrose-containing solutions protect against oxidation and loss of potency 6

Administration Route

Central venous access is strongly preferred to minimize extravasation risk and tissue necrosis. 1, 2, 3

  • If central access is unavailable or delayed, peripheral IV administration can be used temporarily with strict monitoring 1, 2
  • Place an arterial catheter as soon as practical for continuous blood pressure monitoring 2

Target Blood Pressure and Titration

Target MAP of 65 mmHg for most patients. 1, 2, 3

  • In previously hypertensive patients, consider targeting MAP no more than 40 mmHg below their baseline systolic pressure 6
  • In pregnant patients (20 weeks gestation to 3 days postpartum), use systolic BP <85 mmHg as the threshold for vasopressor initiation 1

Monitor blood pressure every 5-15 minutes during initial titration. 2, 3

  • Assess tissue perfusion markers: lactate clearance, urine output >50 mL/h, mental status, capillary refill 2, 3
  • Titrate dose to achieve both MAP target AND adequate tissue perfusion, not just blood pressure alone 2

Maintenance and Escalation

Typical maintenance dose ranges from 2-4 mcg/min (0.5-1 mL/min of standard dilution). 6

  • Maximum doses can be much higher (up to 68 mg/day or 3 mg/h) if hypotension persists, but always suspect and correct occult hypovolemia first 6, 2

When norepinephrine reaches 0.1-0.25 mcg/kg/min and hypotension persists, add vasopressin 0.03-0.04 units/min as second-line therapy rather than continuing to escalate norepinephrine alone. 1, 2, 3

  • Consider adding epinephrine 0.1-0.5 mcg/kg/min if persistent hypoperfusion despite adequate vasopressors 2
  • For persistent hypoperfusion with myocardial dysfunction, add dobutamine up to 20 mcg/kg/min 2

Special Populations

Pregnant patients with septic shock: Start at 0.02 mcg/kg/min, consider more restrictive initial fluid boluses (1-2 L) due to lower colloid oncotic pressure and higher pulmonary edema risk. 1, 3

Pediatric patients: Start at 0.1 mcg/kg/min, titrate to effect, typical range 0.1-1.0 mcg/kg/min, maximum up to 5 mcg/kg/min may be necessary. 2

Critical Pitfalls to Avoid

  • Never start norepinephrine without addressing hypovolemia first (except in life-threatening hypotension), as vasoconstriction in hypovolemic patients causes severe organ hypoperfusion despite "normal" blood pressure 2, 3
  • Do not use dopamine as first-line agent—it is associated with higher mortality and more arrhythmias compared to norepinephrine 2, 7
  • Avoid phenylephrine as first-line therapy—it may raise blood pressure while worsening tissue perfusion 2
  • Monitor for extravasation continuously—if it occurs, immediately infiltrate 5-10 mg phentolamine diluted in 10-15 mL saline at the site to prevent tissue necrosis 2, 7, 6
  • Do not mix with sodium bicarbonate or alkaline solutions—norepinephrine is inactivated in alkaline solutions 2

Evidence for Early Administration

Recent high-quality evidence demonstrates that early norepinephrine administration (simultaneously with fluid resuscitation) significantly improves outcomes in septic shock. 5 A 2019 randomized controlled trial showed that early norepinephrine at 0.05 mcg/kg/min increased shock control rates from 48.4% to 76.1% by 6 hours and reduced cardiogenic pulmonary edema (14.4% vs 27.7%) and new-onset arrhythmias (11% vs 20%). 5 Early administration increases cardiac output and preload, improves microcirculation, and avoids fluid overload. 8

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Norepinephrine Drip Administration Protocol

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Norepinephrine Infusion Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Early Use of Norepinephrine in Septic Shock Resuscitation (CENSER). A Randomized Trial.

American journal of respiratory and critical care medicine, 2019

Guideline

Norepinephrine Dosing for Hypotension

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.